BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18064397)

  • 1. Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review.
    Kuo CF; Tsai WP; Liou LB
    Clin Rheumatol; 2008 Feb; 27(2):231-5. PubMed ID: 18064397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistent rheumatoid arthritis and gout: a case series and review of the literature.
    Olaru L; Soong L; Dhillon S; Yacyshyn E
    Clin Rheumatol; 2017 Dec; 36(12):2835-2838. PubMed ID: 29022182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimized treatment of a patient having rheumatoid arthritis and gout at the same time].
    Nordström D; Leirisalo-Repo M; Petterson T
    Duodecim; 2013; 129(10):1045-8. PubMed ID: 23767136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of gout in rheumatoid arthritis: A case report.
    Zhao G; Wang X; Fu P
    Medicine (Baltimore); 2018 Dec; 97(50):e13540. PubMed ID: 30558013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis and therapy of gout].
    Reuss-Borst M
    Med Klin (Munich); 2009 Sep; 104(9):710-20, quiz 721-2. PubMed ID: 19779676
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
    Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
    Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
    Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
    Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
    Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T
    Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Ahmed MM; Mubashir E; Wolf RE; Hayat S; Hall V; Shi R; Berney SM
    South Med J; 2006 Nov; 99(11):1209-15. PubMed ID: 17195414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coexistence of gout and rheumatoid arthritis: case reports and a review of the literature.
    Rizzoli AJ; Trujeque L; Bankhurst AD
    J Rheumatol; 1980; 7(3):316-24. PubMed ID: 7401066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
    Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA
    Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
    Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study.
    Emamifar A; Hangaard J; Jensen Hansen IM
    Medicine (Baltimore); 2017 Oct; 96(43):e8357. PubMed ID: 29069018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of complicated gout.
    Wise CM; Agudelo CA
    Bull Rheum Dis; 1998 Jun; 47(4):2-5. PubMed ID: 9624822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.
    Mikuls TR; O'Dell JR; Stoner JA; Parrish LA; Arend WP; Norris JM; Holers VM
    Arthritis Rheum; 2004 Dec; 50(12):3776-82. PubMed ID: 15593224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.